button bars forest bayes pooled summary circles
 
deaths (OS)

mML - L2 - all population metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - all population

versus Standard of Care (SoC)
pembrolizumab (2mg/kg) vs. Standard of Care (SoC) 1 1.0better0.35.088 %

mML - L2 - BRAF mutant metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - BRAF mutant

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons